Viewing Study NCT00792012


Ignite Creation Date: 2025-12-26 @ 11:09 AM
Ignite Modification Date: 2025-12-31 @ 12:27 PM
Study NCT ID: NCT00792012
Status: COMPLETED
Last Update Posted: 2017-03-27
First Post: 2008-11-13
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Dose Per Fraction Escalation Trial of Hypofractionated IMRT With Temozolomide for Newly Diagnosed Glioblastoma
Sponsor: University of Colorado, Denver
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module